Front Page-Rx

At NASHP’s 30th State Health Policy Conference, state leaders from legislative and executive branches across the nation gathered to talk about what they are doing to manage escalating prescription drug costs in their states. Several states have recently passed or proposed legislation to force more transparency in drug pricing or to try to regulate drug […]

Read More
  • State Health Policy Blog

    The National Academy for State Health Policy’s (NASHP) has crafted model legislation – called the Prescription Drug Rate-Setting Model Act – that states can use to regulate drug costs. The legislation creates a drug cost review commission that evaluates the affordability of certain drugs in the same way that states now regulate Medicaid, state employee […]

    Read More
    October 17, 2017 | Filed under: Blog Posts, Front Page, Front Page-Rx, State Health Policy Blog
  • NASHP Awards Grants to Colorado, Delaware, and Oklahoma to Tackle Rising Rx Drug Prices
    State Health Policy Blog

    The National Academy for State Health Policy (NASHP) has awarded $300,000 in grants to Colorado, Delaware, and Oklahoma to help the states develop innovative policy solutions to tackle high prescription drug prices. With the support from the Laura and John Arnold Foundation, the funding enables states to explore promising policy approaches to control rapidly escalating […]

    Read More
  • Lowering Drug Costs: Transparency Legislation Sets Off Flurry of New State Approaches
    State Health Policy Blog

    Responding to rapidly rising drug costs, 30 states across the country have drafted more than 60 drug price transparency bills designed to: Identify the costs that contribute to drug manufacturer expenses and list prices And unveil the often opaque business practices of pharmacy benefit managers (PBMs). In addition to promoting pricing transparency, as of early […]

    Read More
  • State Health Policy Blog

    States are searching for new and innovative approaches to handle the rising cost of prescription medicines – both the sudden spike in spending that comes with a new high-cost treatment and the ongoing challenges of regular, inexplicable, price hikes for all covered drugs. The United States has the highest prescription drug prices in the world. […]

    Read More
  • The National Academy for State Health Policy (NASHP), with support from the Laura and John Arnold Foundation, today launched the Center for State Rx Drug Pricing. Building on the work of the Pharmacy Costs Work Group, the Center will provide technical and strategic assistance to states, leverage legal and actuarial expertise as needed, distribute funding […]

    Read More
    June 20, 2017 | Filed under: Front Page-Rx, Pharmaceutical Costs, Prescription Drugs
  • State Health Policy Blog

    In its May 30, 2017 decision Impression Products, Inc. v Lexmark International Inc., the Supreme Court ruled that patent law cannot be used to prevent the resale of products back into the United States. The Court case specifically concerned printer toner cartridges, but it is an important ruling in the context of the domestic policy […]

    Read More
  • Publications

    Because the federal government has not been able to agree on an approach to constrain prescription drug prices, states need to address the problem. Study after study show how U.S. consumers pay the highest prices in the world for life-saving and life-enhancing drug treatments. The prices we pay may fund the research and development that […]

    Read More
  • State Health Policy Blog

    There is growing public pressure to find an effective way to address the rising prices of prescription drugs. Multiple drug price bills await action in Congress and more than 80 bills have been introduced in state legislatures in 2017. Among the variety of approaches aimed at managing drug prices, importation from other countries is an […]

    Read More
  • State Health Policy Blog

    With 80 bills introduced in 2017, there is a high level of interest in pharmaceutical pricing among state legislators. However, despite legislative sessions wrapping up, very few laws have been enacted. To date, bills have passed in Maryland, Montana, New Mexico, New York, and Utah. In 2016, Vermont led the way with a price transparency […]

    Read More